SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer
Authors:
- Masashi NakayamaMNMasashi Nakayama
- Daizo OkaDODaizo Oka
- Mutsumi TsuchiyaMTMutsumi Tsuchiya
- Atsunari KawashimaAKAtsunari Kawashima
- Masatoshi MukaiMMMasatoshi Mukai
- Yasutomo NakaiYNYasutomo Nakai
- Hitoshi TakayamaHTHitoshi Takayama
- Kazuo NishimuraKNKazuo Nishimura
- Yoshimasa JoYJYoshimasa Jo
- Atsushi NagaiANAtsushi Nagai
- Akihiko OkuyamaAOAkihiko Okuyama
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 391 (4) , 1641-1646
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- First international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursBritish Journal of Cancer, 2006
- VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheNature, 2005
- Functional Correlation of Trophinin Expression with the Malignancy of Testicular Germ Cell TumorCancer Research, 2004
- Angiogenetic Protooncogene ets-1 Induced Neovascularization Is Involved in the Metastatic Process of Testicular Germ Cell TumorsEuropean Urology, 2003
- Western and eastern European trends in testicular cancer mortalityThe Lancet, 2001
- Establishment and Characterization of a New Human Testicular Seminoma Cell Line, JKT‐1International Journal of Urology, 1998
- Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.Journal of Clinical Oncology, 1998
- Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel “paraffin”-reactive MIB1 antibodyHuman Pathology, 1994
- pEF-BOS, a powerful mammalian expression vectorNucleic Acids Research, 1990
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987